Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureCem Onal, Aysenur Elmali
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Stereotactic ablative radiation therapy for oligoprogressive metastatic RCC: Predictors of prolonged benefit from ongoing systemic therapy
10.1016/j.ijrobp.2026.02.215 · 2026
Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma
10.1056/nejmoa1803675 · 2018
Cytoreductive nephrectomy in metastatic renal cell carcinoma treated with targeted therapies: A systematic review with a meta-analysis
10.1016/j.clgc.2016.04.001 · 2016
Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: A multi-institutional study
10.1007/s00066-022-02026-w · 2023
The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma
10.1007/s12094-022-02793-z · 2022
No additional external references are available.